Lymphoma: The Bête Noire of the Long-term Use of Thiopurines in Adult and Elderly Patients With Inflammatory Bowel Disease

This publication has 20 references indexed in Scilit:

• Risk of Lymphoma in Patients With Ulcerative Colitis Treated With Thiopurines: A Nationwide Retrospective Cohort Study
  Gastroenterology, 2013
• Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease
  Gastroenterology, 2013
• Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease
  Gastroenterology, 2012
• Inflammatory bowel disease therapies and cancer risk: where are we and where are we going?
  Gut, 2011
• Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease
  Gastroenterology, 2011
• Association of Crohn’s Disease, Thiopurines, and Primary Epstein-Barr Virus Infection with Hemophagocytic Lymphohistiocytosis
  The Journal of Pediatrics, 2011
• Epidemiology of lymphomas
  Histopathology, 2011
• Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
  The Lancet, 2009
• Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease
  Gastroenterology, 2008
• Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry
  Clinical Gastroenterology and Hepatology, 2006